SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-24-021746
Filing Date
2024-04-24
Accepted
2024-04-24 16:31:51
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20023928x2_defa14a.htm DEFA14A 12133
2 ny20023928x2_nc01.jpg GRAPHIC 417297
3 ny20023928x2_nc02.jpg GRAPHIC 299077
  Complete submission text file 0001140361-24-021746.txt   1000199
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Filer) CIK: 0001821586 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39630 | Film No.: 24871045
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)